Mercury Biopharmaceutical Corporation

6932

TW0006932007

Pharmaceuticals

End-of-day quote Taipei Exchange Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
15.85 ^TWD	+12.01%		+30.45%	-15.24%

04-24	Mercury Biopharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Mercury Biopharmaceutical Corporation(TPEX:6932) added to S&P Global BMI Index	CI

Mercury Biopharmaceutical Corporation(TPEX:6932) added to S&P Global BMI Index

June 19, 2023 at 05:00 am

Latest news about Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
Mercury Biopharmaceutical Corporation(TPEX:6932) added to S&P Global BMI Index	19/06/23	CI

Chart Mercury Biopharmaceutical Corporation

Duration

Period

Chart Mercury Biopharmaceutical Corporation

More charts

Merdury Biopharmaceutical Corp is a Taiwan-based company mainly engaged in the research, development and sale of pharmaceuticals. The Company mainly focuses on the development of drugs that do not meet special medical needs, difficult generic drugs and second-class new drugs. With the self-developed and multi-national patented drug development platform StackDose, the Company can develop products that can achieve controllable time-dissolving (instant or sustained release) tablets, thereby controlling the time for the drug to take effect. The main products include Sildenafil, Metformin, Tadalafil, Zolpidem, angina drugs, migraine drugs, multi-ingredient antihypertensive drugs and others. The products are mainly sold in Taiwan and the United States.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
MERCURY BIOPHARMACEUTICAL CORPORATION	-15.24%	203M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals